Scarica l'app Stockscreener
5.15
9.01%
-0.51
Dopo l'orario di chiusura:
5.15
Precedente Chiudi:
$5.66
Aprire:
$5.08
Volume 24 ore:
945.22K
Relative Volume:
1.32
Capitalizzazione di mercato:
$663.37M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-57.22
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
-10.28%
1M Prestazione:
-20.65%
6M Prestazione:
-23.25%
1 anno Prestazione:
-31.79%
Intervallo 1D:
$4.90
$5.40
Intervallo di 1 settimana:
$4.90
$6.01
Portata 52W:
$4.66
$9.3283
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
5.15 | 663.37M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences (NASDAQ:CTKB) Shares Gap DownWhat's Next? - MarketBeat
The Goldman Sachs Group Downgrades Cytek Biosciences (NASDAQ:CTKB) to Sell - MarketBeat
(CTKB) Trading Report - Stock Traders Daily
Cytek cut from buy to sell by Goldman Sachs (CTKB:NASDAQ) - Seeking Alpha
Goldman Sachs Downgrades Cytek Biosciences to Sell From Buy, Adjusts Price Target to $4.50 From $7 - Marketscreener.com
Goldman Sachs cuts Cytek Biosciences stock rating to sell - Investing.com
Cytek Biosciences (NASDAQ:CTKB) Shares Down 5.5%Here's What Happened - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance
Institutional investors may adopt severe steps after Cytek Biosciences, Inc.'s (NASDAQ:CTKB) latest 24% drop adds to a year losses - Simply Wall St
JPMorgan Chase & Co. Lowers Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Preliminary Full Year 2024 Revenue Results AnnouncedOn January 15, 2025, Cytek Biosciences, Inc. released its preliminary unaudited revenue for the fourth quarter and full year that concluded on December 31, 2024. T - Defense World
Cytek Biosciences expects FY24 revenue to be between $200M and $201M - MSN
Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results - GlobeNewswire
Cytek Biosciences, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 - Marketscreener.com
Cytek Biosciences shares take a hit after Q4 sales miss estimates By Investing.com - Investing.com South Africa
Cytek Biosciences shares take a hit after Q4 sales miss estimates - Investing.com Canada
Cytek Biosciences reports 4% annual revenue growth By Investing.com - Investing.com Australia
Cytek Biosciences Shares Fall On Low Preliminary 4Q Revenue - MarketWatch
Cytek Biosciences reports 4% annual revenue growth - Investing.com
Cytek Biosciences Projects 4% Revenue Growth to $201M for 2024, Mixed Q4 Performance - StockTitan
GAMMA Investing LLC Acquires 3,635 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Barclays PLC Increases Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Barclays PLC Has $1.12 Million Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Stock Price Up 5.9%What's Next? - MarketBeat
Upgrading Cytek Biosciences Stock On An Upcoming Catalyst (NASDAQ:CTKB) - Seeking Alpha
Principal Financial Group Inc. Has $2.79 Million Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Jane Street Group LLC Has $756,000 Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Cytek Biosciences to Present at J.P. Morgan Healthcare Conference 2024: Key Investor Event - StockTitan
76,117 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Acquired by Franklin Resources Inc. - Defense World
(CTKB) Technical Data - Stock Traders Daily
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Down 6.6% in December - MarketBeat
Stock Buyback Program Announced by Cytek Biosciences (NASDAQ:CTKB) Board of Directors - Defense World
Cytek Biosciences (NASDAQ:CTKB) to Buyback $50.00 million in Stock - MarketBeat
Cytek Biosciences, Inc. authorizes a Buyback Plan. - Marketscreener.com
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Acquired by Barclays PLC - Defense World
Crude Oil Gains 1%; Chicago PMI Falls In December - Benzinga
Cytek Biosciences (NASDAQ:CTKB) Trading 5.9% HigherWhat's Next? - MarketBeat
Cytek Biosciences stock jumps on new $50M buyback plan By Investing.com - Investing.com Nigeria
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025 - GlobeNewswire
Cytek Biosciences Announces New $50 Million Share Buyback Program for 2025 - StockTitan
Geode Capital Management LLC Buys 89,210 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Barclays PLC Has $1.12 Million Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Geode Capital Management LLC - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by State Street Corp - Defense World
State Street Corp Has $23.09 Million Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
(CTKB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Cytek Biosciences (NASDAQ:CTKB) Trading Up 4.8%Should You Buy? - MarketBeat
The Manufacturers Life Insurance Company Lowers Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):